Literature DB >> 20730767

Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.

Sheena Abraham1, Steven D Sheridan, Bradley Miller, Raj R Rao.   

Abstract

Human pluripotent stem cells (hPSCs) that include human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) have gained enormous interest as potential sources for regenerative biomedical therapies and model systems for studying early development. Traditionally, mouse embryonic fibroblasts have been used as a supportive feeder layer for the sustained propagation of hPSCs. However, the use of nonhuman-derived feeders presents concerns about the possibility of xenogenic contamination, labor intensiveness, and variability in experimental results in hPSC cultures. Toward addressing some of these concerns, we report the propagation of three different hPSCs on feeder-free extracellular matrix (ECM)-based substrates derived from human fibroblasts. hPSCs propagated in this setting were indistinguishable by multiple criteria, including colony morphology, expression of pluripotency protein markers, trilineage in vitro differentiation, and gene expression patterns, from hPSCs cultured directly on a fibroblast feeder layer. Further, hPSCs maintained a normal karyotype when analyzed after 15 passages in this setting. Development of this ECM-based culture system is a significant advance in hPSC propagation methods as it could serve as a critical component in the development of humanized propagation systems for the production of stable hPSCs and its derivatives for research and therapeutic applications. (c) 2010 American Institute of Chemical Engineers

Entities:  

Mesh:

Year:  2010        PMID: 20730767     DOI: 10.1002/btpr.412

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  10 in total

1.  A practical way to prepare primer human chondrocyte culture.

Authors:  Mehmet Isyar; Ibrahim Yilmaz; Duygu Yasar Sirin; Sercan Yalcin; Olcay Guler; Mahir Mahirogullari
Journal:  J Orthop       Date:  2016-04-01

2.  mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.

Authors:  Harrison E Grace; Patrick Galdun; Edward J Lesnefsky; Franklin D West; Shilpa Iyer
Journal:  Stem Cells Dev       Date:  2019-05-20       Impact factor: 3.272

Review 3.  Bioengineering embryonic stem cell microenvironments for the study of breast cancer.

Authors:  Nurazhani Abdul Raof; Bridget M Mooney; Yubing Xie
Journal:  Int J Mol Sci       Date:  2011-11-08       Impact factor: 5.923

4.  Knockdown of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence.

Authors:  Khaled N Alsayegh; Venkat S Gadepalli; Shilpa Iyer; Raj R Rao
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 5.  Tissue specific microenvironments: a key tool for tissue engineering and regenerative medicine.

Authors:  Patrick C Sachs; Peter A Mollica; Robert D Bruno
Journal:  J Biol Eng       Date:  2017-11-16       Impact factor: 4.355

6.  Knockdown of CDK2AP1 in human embryonic stem cells reduces the threshold of differentiation.

Authors:  Khaled N Alsayegh; Steven D Sheridan; Shilpa Iyer; Raj Raghavendra Rao
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

7.  Bioengineered Bruch's-like extracellular matrix promotes retinal pigment epithelial differentiation.

Authors:  Samuel McLenachan; Erwei Hao; Dan Zhang; Ling Zhang; Michael Edel; Fred Chen
Journal:  Biochem Biophys Rep       Date:  2017-03-28

8.  Extracellular matrix aggregates from differentiating embryoid bodies as a scaffold to support ESC proliferation and differentiation.

Authors:  Saik-Kia Goh; Phillip Olsen; Ipsita Banerjee
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

9.  Hair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells.

Authors:  Vanessa Carvalho Coelho de Oliveira; Danúbia Silva Dos Santos; Leandro Vairo; Tais Hanae Kasai Brunswick; Luiz Alberto Soares Pimentel; Adriana Bastos Carvalho; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  Exp Ther Med       Date:  2017-03-08       Impact factor: 2.447

10.  ARHGDIA Confers Selective Advantage to Dissociated Human Pluripotent Stem Cells.

Authors:  Marion J Riggs; Steven D Sheridan; Raj R Rao
Journal:  Stem Cells Dev       Date:  2021-06-29       Impact factor: 3.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.